Document Preview Unavailable

KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC

Cinausero Marika; Laprovitera Noemi; Maglio, Giovanna De; Gerratana Lorenzo; Riefolo Mattia; et al.  Therapeutic Advances in Medical Oncology Vol. 11,  (Jan 2019).

You might have access to this document